Alert button
Picture for Shixu Lin

Shixu Lin

Alert button

Streamlining Social Media Information Retrieval for Public Health Research with Deep Learning

Add code
Bookmark button
Alert button
Jun 28, 2023
Yining Hua, Shixu Lin, Minghui Li, Yujie Zhang, Peilin Zhou, Ying-Chih Lo, Li Zhou, Jie Yang

Figure 1 for Streamlining Social Media Information Retrieval for Public Health Research with Deep Learning
Figure 2 for Streamlining Social Media Information Retrieval for Public Health Research with Deep Learning
Figure 3 for Streamlining Social Media Information Retrieval for Public Health Research with Deep Learning
Figure 4 for Streamlining Social Media Information Retrieval for Public Health Research with Deep Learning
Viaarxiv icon

Exploring Social Media for Early Detection of Depression in COVID-19 Patients

Add code
Bookmark button
Alert button
Feb 23, 2023
Jiageng Wu, Xian Wu, Yining Hua, Shixu Lin, Yefeng Zheng, Jie Yang

Figure 1 for Exploring Social Media for Early Detection of Depression in COVID-19 Patients
Figure 2 for Exploring Social Media for Early Detection of Depression in COVID-19 Patients
Figure 3 for Exploring Social Media for Early Detection of Depression in COVID-19 Patients
Figure 4 for Exploring Social Media for Early Detection of Depression in COVID-19 Patients
Viaarxiv icon

Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications

Add code
Bookmark button
Alert button
Jun 29, 2022
Yining Hua, Hang Jiang, Shixu Lin, Jie Yang, Joseph M. Plasek, David W. Bates, Li Zhou

Figure 1 for Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications
Figure 2 for Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications
Figure 3 for Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications
Figure 4 for Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications
Viaarxiv icon